OlympusTSE:7733 -3.12%81 Interest Coverage is 52.07 as of Mar. 2026, which is 334% above its 10-year median of 11.99. GuruFocus rates TSE:7733 with a GF Score™ of 81/100 and a GF Value™ of 円2,595.30 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 466 Medical Devices & Instruments companies, Olympus ranks worse than 57.3% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Olympus's
Operating Income
for the
three
months ended in Mar. 2026 was 円26,866 Mil. Olympus's Interest Expense for the
three
months ended in Mar. 2026 was 円-516 Mil.
Olympus's interest coverage for the quarter that ended in Mar. 2026 was 52.07.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Olympus's Interest Coverage or its related term are showing as below:
TSE:7733'
s Interest Coverage Range Over the Past 10 Years
Min: 2.67 Med: 11.99 Max: 24.79
Current: 10.84
TSE:7733's Interest Coverage is ranked worse than 57.3% of 466
companies
in the Medical Devices & Instruments industry
Industry Median: 15.875
vs TSE:7733: 10.84
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Olympus Interest Coverage Related Terms
Olympus Interest Coverage Historical Data
* Premium members only.
The historical data trend for Olympus's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
TSE:7733 vs ABT, SYK, MDT: Interest Coverage Comparison
For the Medical Devices subindustry, Olympus's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Olympus Interest Coverage vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Olympus's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Olympus's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Olympus (TSE:7733) has a Interest Coverage of 52.07 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Olympus and its competitors. This is 334% above median its historical median of 11.99. Over the past decade, Olympus' Interest Coverage has ranged from 2.67 to 24.79. According to the industry distribution chart, Olympus ranks #267 out of 466 companies in the Medical Devices & Instruments industry, placing it in the top 57.3%.
Is Olympus' Interest Coverage too high?
Olympus' current Interest Coverage of 52.07 is 334% above median its 10-year median of 11.99. Over the past 10 years, this metric has ranged from a low of 2.67 to a high of 24.79. The Medical Devices & Instruments industry median Interest Coverage is 15.88. Olympus' value of 52.07 is 228% above this industry median. Based on the distribution chart, Olympus ranks #267 out of 466 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Olympus has a GF Score™ of 81/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Olympus' Interest Coverage compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Olympus ranks #267 out of 466 companies for Interest Coverage. This places Olympus in the lower half of its industry. The industry median Interest Coverage is 15.88. Olympus' value of 52.07 is 228% above this benchmark. Historically, Olympus' own Interest Coverage has ranged from 2.67 to 24.79 over the past decade. While the company's 10-year median is 11.99 vs. the industry median of 15.88, Olympus has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Medical Devices & Instruments company?
The median Interest Coverage among Medical Devices & Instruments companies is 15.88, based on 466 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Olympus's current Interest Coverage of 52.07 is 228% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Olympus and its competitors. For the Medical Devices & Instruments industry, the median Interest Coverage is 15.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Olympus's current Interest Coverage is 52.07, which is 334% above median its own 10-year median of 11.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Olympus stock overvalued right now?
Based on GuruFocus' analysis, Olympus (TSE:7733) is currently considered Significantly Undervalued. The stock's GF Value™ is 円2,595.30, compared to a current price of 円1,646.00 — trading 36.6% below its estimated fair value. The current Interest Coverage is 52.07, which is 334% above median its 10-year median of 11.99 and 228% above the Medical Devices & Instruments industry median of 15.88. Olympus' overall GF Score™ is 81/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Olympus (TSE:7733), the current Interest Coverage is 52.07 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Olympus (TSE:7733) Overvalued in 2026?
Based on GuruFocus' analysis, Olympus stock appears to be undervalued.
The current stock price of 円1,646.00 is trading 36.6% below its estimated GF Value™ of 円2,595.30.
GuruFocus considers Olympus to be Significantly Undervalued.
Key valuation signals for TSE:7733:
Interest Coverage: 52.07 (334% above median its 10-year median of 11.99)
GF Value™: 円2,595.30 vs. price of 円1,646.00 (36.6% below fair value)
Industry Position: 228% above the Medical Devices & Instruments median (#267 of 466)
No single metric tells the full story. See the TSE:7733 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Olympus is a medical-device maker with a leading position in the endoscope market and a diversified global revenue stream. Originally founded in 1919 in Japan as a microscope and camera maker, Olympus has gradually pivoted into endoscopic and therapeutic solutions. As of March 2025, more than 60% of its revenue comes from endoscopic solutions. In addition, North America is the biggest revenue contributor by region, accounting for 38% of its total revenue.
81GF Score
Get the complete analysis for TSE:7733
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7733 has been successfully added to your 
